Counting and sizing sub-visible particles formed during the preparation of protein therapeutics is critical for assessing product quality and safety during development, yet technical challenges persist in monitoring and controlling them. The goal of this webinar is to provide attendees with an overview of emerging particle analysis technologies for use in the characterization and quality control of biologics during biopharmaceutical processing. Attendees can interact with the experts during the live webinar by asking questions and sharing their experiences on this topic.
Topics to be covered:
Dr. Shawn Cao
Principal Scientist
Process and Product Development
Amgen
Dr. Yuling Li
R&D Fellow (Scientific Director)
Biopharmaceutical Development
MedImmune
